Innovation and Product Development news (page 10)

• 

  13 May 2026

  Trinseo launches VOLTABOND 211 SBR binder for fast-charging batteries

  A new water‑based SBR anode binder for graphite/silicon minimizes binder migration, lowers surface resistivity ~5% and whole‑cell DCIR up to 18%, while retaining adhesion and heat resistance.
• 

  13 May 2026

  Perpetual Next selects Clarksons to broker maritime biomethanol

  Chosen broker will market scalable, waste-to-biomethanol via international offtake, finance and logistics for maritime bunkering as demand rises with decarbonization rules.
• 

  13 May 2026

  Novo Nordisk: Wegovy pill yields 21.6% weight loss in early responders and doubles mobility improvement

  Nearly 29% were early responders (≥10% by 16w), averaging 13.2% loss at 16w; non-responders still lost 11.5% by wk64. Overall mean 17% vs 2.7% placebo. Outperformed orforglipron; GI AEs mostly mild.
• 

  12 May 2026

  Lilly: Foundayo and reduced-dose Zepbound maintain weight loss after switching from high-dose injectables

  Two late-phase trials: switching from high-dose injectable incretins to an oral GLP-1 or reducing injectable dose preserved most prior weight loss at 1 year; safety matched prior Phase 3
• 

  12 May 2026

  Boehringer Ingelheim licenses Immunitas preclinical antibody program for chronic inflammatory diseases

  Global license of a preclinical antibody that targets pathogenic cells at inflammation sites to provide durable control in chronic immune diseases; includes milestones to €407.5M +royalties
• 

  12 May 2026

  Novo Nordisk: Wegovy cuts weight and reduces cardiovascular and migraine risk across menopausal stages

  Trials and real‑world data: semaglutide gave 19.7–22.6% weight loss, 15–17.5% waist reduction, ~42% MACE risk reduction in perimenopause, 42–45% lower migraine and 25% lower depression risk

• 

  12 May 2026

  Eni and MSC Cruises test Enilive HVO diesel on cruise ship

  Pure HVO ran ~2,000 hours on a ship engine with no modifications; matched fuel performance, cut NOx ~16% and particulates, and cut lifecycle GHG ~80%. Validated by maker and independent certifier.
• 

  12 May 2026

  Coolbrook appoints Dr Frank Eulitz CTO to lead industrial scale-up

  Veteran turbomachinery expert brings 30+ years' R&D and OEM experience to lead scale-up and manufacturing of RotoDynamic electrification tech for high-temperature, fossil-free industrial heat
• 

  12 May 2026

  Novo Nordisk: Wegovy 7.2 mg yields ~28% weight loss in early responders

  STEP UP trial: early responders (≥15% at 24w) sustained major weight loss at 72w; higher dose reached goals faster than 2.4 mg; 84% of lost weight was fat and muscle function preserved.
• 

  11 May 2026

  ASPİLSAN Enerji A35 3500 mAh 18650 silicon/graphite cell

  New 18650 lithium‑ion cell delivers 3500 mAh using a silicon/graphite composite anode; shown at SAHA 2026 and positioned for defense, mobility and global markets, including the USA.
• 

  11 May 2026

  PTT Global Chemical Tops S&P Global Sustainability Ranking for 7th Year

  Ranked Top 1% in S&P Global CSA for seven consecutive years; the first company to do so. Named Sustainability Yearbook Member 13 years and added to Dow Jones Best‑in‑Class World and Emerging indices.
• 

  11 May 2026

  Worley partners with Baker Hughes to deliver integrated LNG solutions

  Non-exclusive MOU to jointly develop integrated, lower-carbon LNG projects - combining EPCM/EPCI delivery, modular liquefaction, advanced turbomachinery and digital tools to derisk and speed delivery
• 

  11 May 2026

  LanzaTech selects North Sea Port, Ghent for Europe’s first commercial ATJ SAF plant

  €500M ATJ project targeting 79,000 t/yr SAF and 9,000 t/yr renewable diesel; EIA scoping filed; ~50 permanent jobs and ~300 FTE construction; FEED complete; EU Horizon support.
• 

  11 May 2026

  BASF Agricultural Solutions opens BioHub fermentation plant in Ludwigshafen

  High double‑digit €m investment started commercial fermentation of biological crop actives (B. amyloliquefaciens, P. coprobium), boosting production flexibility and supply resilience.
• 

  11 May 2026

  GSK partners with Sino Biopharmaceutical (CTTQ) for exclusive China launch of bepirovirsen

  Potential first-in-class CHB treatment under priority review in China; deal provides access to 5,000+ medical centres at launch, local import/distribution, hospital access and initial 5.5-yr supply.
• 

  11 May 2026

  Shanghai Petrochemical commissions phase‑one of 30,000‑t large‑tow carbon fiber project — China’s largest 48K single‑line

  Phase-one (2 lines) of a 30,000-t large-tow carbon-fiber project in Ordos began production. Single-line >3,000 t (48K); +50% capacity, 188-day build, >60% green power
• 

  9 May 2026

  Uniper demolishes Scholven towers D & E for H2-ready CCGT

  Two 114 m cooling towers were demolished at 11:00; ~15,000 t of concrete will be recycled for site backfill. Demolition used a coordinated safety plan; no resident evacuations.
• 

  8 May 2026

  argenx: FDA expands VYVGART/VYVGART Hytrulo approval to all adult gMG patients

  Phase-3 ADAPT SERON: VYVGART showed rapid, significant, sustained improvements across anti-MuSK, anti-LRP4 and triple-seronegative gMG; safety consistent; IV/SC options; access support.
• 

  8 May 2026

  Clariant Q1 2026: Resilient performance amid Middle East conflict

  Q1 sales down 2% (CHF918m); EBITDA margin fell to 17.5% (-130bp). Free cash-flow conversion rose to 54%. CHF80m savings program on track; 2026 guidance unchanged amid conflict
• 

  7 May 2026

  argenx Q1 2026 Financial Results & Business Update

  Q1 product sales $1.3B (+63% YoY); profit $366M; PDUFA May 10 for seronegative gMG; VYVGART label expansions, multiple pipeline readouts in 2026–27; cash $4.9B
• 

  7 May 2026

  PureCycle Achieves A3 CosPaTox Rating for Leave‑On Cosmetic‑Grade PureFive Resin

  Independent study shows dissolution recycling converts post‑consumer polypropylene into A3 leave‑on cosmetic grade resin commercially, removing contaminants, retaining performance and lowering CO₂
• 

  7 May 2026

  Moeve Q1 2026 Clean CCS EBITDA €506m, ramps Spain energy-transition capex

  Q1 net income €147m; capex €272m (69% to energy transition); operating cash flow €283m; FID for 300MW Andalusian green hydrogen; non-binding talks with Galp; net debt €2.56bn (1.6x).
• 

  7 May 2026

  SPIE Joins Consortium to Build PanTera Actinium‑225 Production Facility in Mol

  Consortium to build facility boosting production of a cancer radioisotope; scope includes HVAC, sanitation and technical gases. Construction started; equipment integration planned late 2026.
• 

  7 May 2026

  UPM, Michelman and BOBST launch EU‑compliant bio‑based paper packaging concepts

  Two paper packaging concepts for EU SUPD: fiber papers with bio-based coatings giving moisture/mineral-oil and oxygen barriers, wide heat-seal window, recyclable/compostable, production-ready.
• 

  7 May 2026

  Roche to acquire PathAI for AI-driven digital pathology

  Adds best‑in‑class Image Management System and AI pathology tools to diagnostics, boosting lab automation, companion diagnostics and biomarker discovery. Deal closes H2; $750M + up to $300M
• 

  7 May 2026

  Sinopec and Nanjing University Form Strategic Partnership

  Agreement deepens R&D, platforms, talent training and think‑tank work; aligns industry‑university‑research‑use to speed innovation and support energy security and green, low‑carbon transition.
• 

  7 May 2026

  MAIRE’s Nextchem awarded licensing and PDP for urea-to-DEF plant in Virginia

  Licensing & PDP won for a 700 STPD urea melt plant in Virginia, fully integrated to convert all urea to DEF; FID/NTP targeted H1 2027; reflects rising DEF demand from tighter emissions.
• 

  6 May 2026

  PureCycle Technologies Q1 2026 Results

  Ironton turnaround finished early/under budget; record 8.4M lb production (~10M lb feedstock); 5th consecutive revenue growth; two P&G approvals; Q1 net loss $33.4M; liquidity $131M.
• 

  6 May 2026

  LanzaTech partners with DTU BRIGHT to build C1 biofoundry

  Multi-year deal to design and install a next-gen C1 biofoundry, accelerating gas fermentation R&D to convert CO, CO2 and methane into fuels, chemicals and materials.
• 

  6 May 2026

  OMV invests €65m in Schwechat Innovation Hub

  New Schwechat hub (8,120 m²) will house labs, pilot plants and a technical centre with 50 workstations and space for up to 15 test facilities. Construction 55% done; start-up H1 2027.